West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.91 by 6.81 percent. This is a 52.24 percent increase over earnings of $1.34 per share from the same period last year. The company reported quarterly sales of $730.80 million which beat the analyst consensus estimate of $710.20 million by 2.90 percent. This is a 25.96 percent increase over sales of $580.20 million the same period last year.
West Pharmaceutical Servs Q4 EPS $2.04 Beats $1.91 Estimate, Sales $730.80M Beat $710.20M Estimate
West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.04 per share which beat the analyst consensus estimate of $1.91 by 6.81 percent. This is a 52.24 percent increase over earnings of $1.34 per share
